http://www.acc.org/Feed?clinicalTopicID=5f25c4ac-b76f-4970-a93c-15cdf264bed5 Clinical Topic Feed: Dyslipidemia en /Latest-in-Cardiology/Journal-Scans/2026/06/23/13/25/Combined-LDL-C-Lpa-and-hsCRP-Assessment Combined assessment of LDL-C, Lp(a) and hsCRP reflected independent pathways for identifying individuals of varied ethnicities at greater long-term risk of atherosclerotic cardiovascular disease (ASCVD), according to an analysis of the HELIUS cohort published June 24 in JACC. 1782413280000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/24/13/30/eagles-eye-view-24jun2026 In this week’s View, Dr. Eagle reviews 21-year follow-up data from the Diabetes Prevention Program (DPP), showing that lifestyle intervention—but not metformin—reduces multimorbidity risk in prediabetes. 1782308100000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/17/16/52/CV-Risk-Factor Treatment of hypertension and hyperlipidemia was low among U.S. adults with cardiovascular-kidney-metabolic (CKM) syndrome, with less than half achieving blood pressure or glycemic control, and gaps in starting treatment were greatest among women, young adults and Hispanic adults. Furthermore, inadequate risk factor control was highest among those with the highest cardiovascular risk, according to research published June 17 in JACC. 1781716440000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/16/16/01/eagles-eye-view-17jun2026 In this week’s View, Dr. Eagle highlights a study showing race and sex disparities in M-TEER outcomes, with Black patients presenting with more advanced disease, lower success, and higher heart failure readmissions than White patients, and women having lower success rates than men. 1781701440000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/15/14/16/Implications-of-the-2026-Multisociety-Dyslipidemia-Guideline Lipid management remains a cornerstone of secondary prevention in atherosclerotic cardiovascular disease (ASCVD), with increasingly strong evidence supporting its central role across all vascular territories, including coronary, cerebrovascular, and peripheral arterial beds. 1781629980000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/08/17/44/SOGALDI-PEF Patients with low plasma renin levels had a more pronounced blood pressure (BP) reduction with spironolactone/dapagliflozin vs. dapagliflozin alone, in addition to seeing a more favorable impact on cardiovascular structure and function, while aldosterone levels exhibited no predictive value in treatment response... 1781118900000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/08/17/44/First-Ever-Guideline-Addresses-CKM-Syndrome The new 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome is the first ever to address the "interrelated condition characterized by the interconnections among metabolic risk factors (including obesity and type 2 diabetes)... 1781028000000 Articles and Stories https://www.jacc.org/doi/10.1016/j.jacc.2026.03.056 1781028000000 Guidelines /Education-and-Meetings/Patient-Case-Quizzes/2026/06/09/16/23/Severe-Hypertriglyceridemia A 48-year-old man with a history of type 2 diabetes mellitus (T2DM), obesity (body mass index 34.0), and heavy alcohol use (approximately four to five drinks daily) presents to the clinic for a routine follow-up. He reports a 3-day history of mild diffuse abdominal discomfort but denies nausea, vomiting, or fever. 1781025180000 Educational Activities /Education-and-Meetings/Patient-Case-Quizzes/2026/06/09/16/23/Recurrent-Extreme-Hypertriglyceridemia A 29-year-old woman is referred to a lipid clinic following her second hospitalization because of acute pancreatitis in 18 months. She has no history of diabetes mellitus, alcohol use, hypothyroidism, or use of triglyceride (TG) level–raising medications. 1781025180000 Educational Activities